Mitra Mosharraf, PhD, M.B.A., CSO, HTD Biosystems will do a talk on "Strategies for Manufacturing and Analysis of Lipid-Based Nanomedicines and Vaccines" at PharmSci 360, on 10th November.
Elliott Zell, global new product marketing manager for Solventum Bioprocessing Filtration looks at reimagining clarification in biopharmaceutical manufacturing.
Bastian Erb, director production engineering, Vetter, shares insights into how robotics and automation — including innovations like the Syringe Speed Picker — are transforming pharmaceutical manufacturing.
With the increasing prevalence of poorly soluble drugs in the pharmaceutical pipeline, Matt Finkelhor, commercial manager, Global Novel Polymers at Lubrizol, explores how to realise therapeutic potential with the right excipients.
ESG - Environmental, Social and Governance - is critically important for a globally active engineering company such as GEA Group AG for several strategic, operational and reputational reasons.
Updesh Dosanjh, practice leader, PV Technology Solutions, IQVIA explores the lesson: digital transformation in pharmacovigilance (PV) must be preceded by foundational business transformation.
Chris Burton, executive vice president of experiences and design, Sign In Solutions shares six visitor management practices to strengthen compliance culture in pharma.
Nick Petschek, managing director EMEA, Kotter International discusses why the UK Government’s Life Sciences Plan Proves that policy needs change management to succeed.
In the pharmaceutical world, packaging is more than just a container. It is the first guardian of patient safety, product integrity, and regulatory trust. Katia Kayam, LOG Pharma, discusses.
